MA33882B1 - Nouveaux derives azabicyclo [3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent - Google Patents
Nouveaux derives azabicyclo [3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennentInfo
- Publication number
- MA33882B1 MA33882B1 MA34932A MA34932A MA33882B1 MA 33882 B1 MA33882 B1 MA 33882B1 MA 34932 A MA34932 A MA 34932A MA 34932 A MA34932 A MA 34932A MA 33882 B1 MA33882 B1 MA 33882B1
- Authority
- MA
- Morocco
- Prior art keywords
- azabycyclo
- hex
- pharmaceutical compositions
- compositions containing
- new derivatives
- Prior art date
Links
- -1 hex-2-yl Chemical group 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0905953A FR2953521B1 (fr) | 2009-12-09 | 2009-12-09 | Nouveaux derives azabicyclo[3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| PCT/FR2010/000823 WO2011070253A1 (fr) | 2009-12-09 | 2010-12-08 | Derives azabicyclo [3.1.0] hex- 2 -yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA33882B1 true MA33882B1 (fr) | 2013-01-02 |
Family
ID=42711699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA34932A MA33882B1 (fr) | 2009-12-09 | 2010-12-08 | Nouveaux derives azabicyclo [3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US20120283245A1 (https=) |
| EP (1) | EP2509947A1 (https=) |
| JP (1) | JP2013513589A (https=) |
| KR (1) | KR20120102763A (https=) |
| CN (1) | CN102652127A (https=) |
| AP (1) | AP2012006352A0 (https=) |
| AR (1) | AR079265A1 (https=) |
| AU (1) | AU2010329762B2 (https=) |
| BR (1) | BR112012013666A2 (https=) |
| CA (1) | CA2782469C (https=) |
| CL (1) | CL2012001479A1 (https=) |
| CO (1) | CO6541535A2 (https=) |
| CR (1) | CR20120286A (https=) |
| CU (1) | CU20120091A7 (https=) |
| EA (1) | EA201200849A1 (https=) |
| EC (1) | ECSP12011950A (https=) |
| FR (1) | FR2953521B1 (https=) |
| GE (1) | GEP20156227B (https=) |
| IN (1) | IN2012DN04966A (https=) |
| MA (1) | MA33882B1 (https=) |
| MX (1) | MX2012006578A (https=) |
| NI (1) | NI201200099A (https=) |
| PE (1) | PE20121475A1 (https=) |
| PH (1) | PH12012501053A1 (https=) |
| SA (1) | SA110320011B1 (https=) |
| SG (1) | SG181082A1 (https=) |
| TN (1) | TN2012000267A1 (https=) |
| TW (1) | TW201200499A (https=) |
| UA (1) | UA102950C2 (https=) |
| UY (1) | UY33072A (https=) |
| WO (1) | WO2011070253A1 (https=) |
| ZA (1) | ZA201203943B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105764510A (zh) * | 2013-09-09 | 2016-07-13 | 赛诺菲 | H3受体拮抗剂与胆碱酶抑制剂组合用于阿尔茨海默氏病治疗中的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2866647B1 (fr) * | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB0507680D0 (en) * | 2005-04-15 | 2005-05-25 | Glaxo Group Ltd | Compounds |
| CN101316835A (zh) * | 2005-11-30 | 2008-12-03 | 霍夫曼-拉罗奇有限公司 | 5-取代的吲哚-2-甲酰胺衍生物 |
-
2009
- 2009-12-09 FR FR0905953A patent/FR2953521B1/fr not_active Expired - Fee Related
-
2010
- 2010-12-01 UY UY0001033072A patent/UY33072A/es unknown
- 2010-12-03 TW TW099142190A patent/TW201200499A/zh unknown
- 2010-12-06 AR ARP100104484A patent/AR079265A1/es not_active Application Discontinuation
- 2010-12-07 SA SA110320011A patent/SA110320011B1/ar unknown
- 2010-12-08 JP JP2012542591A patent/JP2013513589A/ja not_active Ceased
- 2010-12-08 MA MA34932A patent/MA33882B1/fr unknown
- 2010-12-08 SG SG2012038931A patent/SG181082A1/en unknown
- 2010-12-08 IN IN4966DEN2012 patent/IN2012DN04966A/en unknown
- 2010-12-08 MX MX2012006578A patent/MX2012006578A/es active IP Right Grant
- 2010-12-08 AU AU2010329762A patent/AU2010329762B2/en not_active Ceased
- 2010-12-08 BR BR112012013666A patent/BR112012013666A2/pt not_active IP Right Cessation
- 2010-12-08 GE GEAP201012774A patent/GEP20156227B/en unknown
- 2010-12-08 KR KR1020127017843A patent/KR20120102763A/ko not_active Ceased
- 2010-12-08 PH PH1/2012/501053A patent/PH12012501053A1/en unknown
- 2010-12-08 EP EP10799080A patent/EP2509947A1/fr not_active Withdrawn
- 2010-12-08 UA UAA201208178A patent/UA102950C2/ru unknown
- 2010-12-08 EA EA201200849A patent/EA201200849A1/ru unknown
- 2010-12-08 CN CN2010800559947A patent/CN102652127A/zh active Pending
- 2010-12-08 PE PE2012000722A patent/PE20121475A1/es not_active Application Discontinuation
- 2010-12-08 WO PCT/FR2010/000823 patent/WO2011070253A1/fr not_active Ceased
- 2010-12-08 US US13/514,796 patent/US20120283245A1/en not_active Abandoned
- 2010-12-08 CA CA2782469A patent/CA2782469C/fr not_active Expired - Fee Related
- 2010-12-08 AP AP2012006352A patent/AP2012006352A0/xx unknown
-
2012
- 2012-05-28 TN TNP2012000267A patent/TN2012000267A1/fr unknown
- 2012-05-29 CR CR20120286A patent/CR20120286A/es unknown
- 2012-05-30 ZA ZA2012/03943A patent/ZA201203943B/en unknown
- 2012-06-05 EC ECSP12011950 patent/ECSP12011950A/es unknown
- 2012-06-06 CL CL2012001479A patent/CL2012001479A1/es unknown
- 2012-06-06 CO CO12095636A patent/CO6541535A2/es unknown
- 2012-06-07 NI NI201200099A patent/NI201200099A/es unknown
- 2012-06-07 CU CU20120091A patent/CU20120091A7/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201190235A1 (ru) | Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750 | |
| EA201170772A1 (ru) | Органические соединения | |
| EA201001205A1 (ru) | Соединения, содержащие циклобутоксигруппу | |
| EA200701176A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
| EA201390908A1 (ru) | Производные бицикло[3.2.1]октиламида и их применение | |
| MY151986A (en) | Adamantyl diamide derivatives and uses of same | |
| UA98623C2 (ru) | Соединения диосметина, способ их получения и фармацевтическая композиция, которая их содержит | |
| ECSP066376A (es) | FORMA CRISTALINA GAMMA-d DEL CLORHIDRATO DE IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN | |
| CY1109637T1 (el) | Νεα τρικυκλικα παραγωγα, η μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα περιεχουν | |
| EA201001087A1 (ru) | Новые дигидроиндолоновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
| EA201001855A1 (ru) | Соединения, содержащие циклобутоксигруппу | |
| TN2012000105A1 (en) | Spirolactam derivatives and uses of same | |
| EA201291014A1 (ru) | Трициклическое индазольное соединение, способ его получения и содержащая его фармацевтическая композиция | |
| TW200714598A (en) | Urea derivatives, methods for their manufacture, and uses therefor | |
| EA200701178A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
| MA33882B1 (fr) | Nouveaux derives azabicyclo [3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| MX2012005596A (es) | Derivados de difenil azepano como inhibidores de reabsorcion de monoaminas. | |
| NO20083352L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
| EA200701177A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
| UA91646C2 (ru) | Соединения индола, способ их получения и фармацевтическая композиция (варианты), которая их содержит | |
| EA200801137A1 (ru) | Соединения для ингибирования апоптоза | |
| EA200900692A1 (ru) | Новые азабициклические соединения, способ их получения и фармацевтические композиции, которые их содержат | |
| ATE522530T1 (de) | 2-piperazin-1-yl-3h-imidazoä4,5-bü- pyridinderivate | |
| EA201001755A1 (ru) | Новые соединения азабицикло[3.2.0]гепт-3-ила, способ их получения и фармацевтические композиции, которые их содержат | |
| EA200601842A1 (ru) | D-гомо-17-хлор-16(17)-ен-стероиды |